Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online ...

A new publication from Genes & Diseases; DOI 10.1016/j.gendis.2024.101284 , discusses the effect of long-term administration of green tea catechins ...

Aging is an independent risk factor for cardiovascular diseases. Cardiac diastolic dysfunction (CDD), ultimately leading to ...

Background Cardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common ...

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a major health concern. Pathological stimuli and interactions between cardiac fibroblasts (CFs) and other cell types may lead to ...

Volenrelaxin is under development for the treatment of chronic heart failure with preserved ejection fraction (HFpEF) (diastolic heart failure), chronic kidney disease. It is a new molecular entity ...

In infants with cardiomyopathy-associated chronic HF, baseline LVEF of less than 40% and β blocker use indicate a decreased chance of LVEF normalization.

Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology (isolated STR).

A third heart sound, or S3, is a low-frequency, extra heart sound that may be heard with a stethoscope right after the normal S1 and S2 heart sounds. S1 and S2 are the "lub-dub" sounds of a heartbeat ...

A robust and systematic approach is key to ensuring that people living with heart failure with preserved ejection fraction (HFpEF) receive a timely and accurate diagnosis and guideline-based therapies ...